Other Assets, Noncurrent in USD of NEOGENOMICS INC from Q4 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Neogenomics Inc quarterly Other Assets, Noncurrent history and change rate from Q4 2010 to Q3 2025.
  • Neogenomics Inc Other Assets, Noncurrent for the quarter ending 30 Sep 2025 was $8.19M, a 46.7% increase year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Change (%)

NEOGENOMICS INC Quarterly Other Assets, Noncurrent (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $8.19M +$2.61M +46.7% 30 Sep 2025 10-Q 28 Oct 2025
Q2 2025 $7.13M +$3.05M +74.9% 30 Jun 2025 10-Q 29 Jul 2025
Q1 2025 $6.01M +$1.54M +34.4% 31 Mar 2025 10-Q 29 Apr 2025
Q4 2024 $5.89M +$1.14M +24.1% 31 Dec 2024 10-Q 28 Oct 2025
Q3 2024 $5.58M +$615K +12.4% 30 Sep 2024 10-Q 05 Nov 2024
Q2 2024 $4.08M -$1.33M -24.6% 30 Jun 2024 10-Q 30 Jul 2024
Q1 2024 $4.47M -$836K -15.8% 31 Mar 2024 10-Q 30 Apr 2024
Q4 2023 $4.74M -$367K -7.18% 31 Dec 2023 10-K 18 Feb 2025
Q3 2023 $4.97M -$1.88M -27.4% 30 Sep 2023 10-Q 06 Nov 2023
Q2 2023 $5.41M -$971K -15.2% 30 Jun 2023 10-Q 08 Aug 2023
Q1 2023 $5.31M -$1.29M -19.6% 31 Mar 2023 10-Q 09 May 2023
Q4 2022 $5.11M -$2.06M -28.7% 31 Dec 2022 10-K 20 Feb 2024
Q3 2022 $6.85M -$365K -5.06% 30 Sep 2022 10-Q 08 Nov 2022
Q2 2022 $6.38M -$1.3M -16.9% 30 Jun 2022 10-Q 09 Aug 2022
Q1 2022 $6.6M +$1.33M +25.2% 31 Mar 2022 10-Q 09 May 2022
Q4 2021 $7.17M +$2.67M +59.2% 31 Dec 2021 10-K 24 Feb 2023
Q3 2021 $7.21M +$3.39M +88.9% 30 Sep 2021 10-Q 04 Nov 2021
Q2 2021 $7.67M +$4.62M +151% 30 Jun 2021 10-Q 09 Aug 2021
Q1 2021 $5.27M +$2.12M +67.2% 31 Mar 2021 10-Q 06 May 2021
Q4 2020 $4.5M +$1.66M +58.2% 31 Dec 2020 10-K 25 Feb 2022
Q3 2020 $3.82M +$603K +18.8% 30 Sep 2020 10-Q 29 Oct 2020
Q2 2020 $3.06M -$275K -8.25% 30 Jun 2020 10-Q 31 Jul 2020
Q1 2020 $3.15M +$327K +11.6% 31 Mar 2020 10-Q 29 Apr 2020
Q4 2019 $2.85M +$309K +12.2% 31 Dec 2019 10-K 25 Feb 2021
Q3 2019 $3.21M +$277K +9.43% 30 Sep 2019 10-Q 13 Nov 2019
Q2 2019 $3.33M +$2.03M +156% 30 Jun 2019 10-Q 07 Aug 2019
Q1 2019 $2.83M +$1.51M +114% 31 Mar 2019 10-Q 08 May 2019
Q4 2018 $2.54M +$1.65M +185% 31 Dec 2018 10-K 28 Feb 2020
Q3 2018 $2.94M +$2.69M +1075% 30 Sep 2018 10-Q 06 Nov 2018
Q2 2018 $1.3M +$1M +331% 30 Jun 2018 10-Q 06 Aug 2018
Q1 2018 $1.32M +$1.15M +690% 31 Mar 2018 10-Q 08 May 2018
Q4 2017 $891K +$717K +412% 31 Dec 2017 10-K 26 Feb 2019
Q3 2017 $250K +$76K +43.7% 30 Sep 2017 10-Q 13 Nov 2017
Q2 2017 $302K +$173K +134% 30 Jun 2017 10-Q 07 Aug 2017
Q1 2017 $167K +$38K +29.5% 31 Mar 2017 10-Q 09 May 2017
Q4 2016 $174K +$45K +34.9% 31 Dec 2016 10-K 13 Mar 2018
Q3 2016 $174K +$45K +34.9% 30 Sep 2016 10-Q 07 Nov 2016
Q2 2016 $129K +$1K +0.78% 30 Jun 2016 10-Q 05 Aug 2016
Q1 2016 $129K -$10K -7.19% 31 Mar 2016 10-Q 10 May 2016
Q4 2015 $129K -$12K -8.51% 31 Dec 2015 10-K 14 Mar 2017
Q3 2015 $129K -$14K -9.79% 30 Sep 2015 10-Q 06 Nov 2015
Q2 2015 $128K +$12K +10.3% 30 Jun 2015 10-Q 31 Jul 2015
Q1 2015 $139K -$40K -22.3% 31 Mar 2015 10-Q 11 May 2015
Q4 2014 $141K -$13K -8.44% 31 Dec 2014 10-K 18 Apr 2016
Q3 2014 $143K -$35K -19.7% 30 Sep 2014 10-Q 04 Nov 2014
Q2 2014 $116K -$54K -31.8% 30 Jun 2014 10-Q 29 Jul 2014
Q1 2014 $179K +$95K +113% 31 Mar 2014 10-Q 12 May 2014
Q4 2013 $154K +$71K +85.5% 31 Dec 2013 10-K 03 Mar 2015
Q3 2013 $178K +$87K +95.6% 30 Sep 2013 10-Q 30 Oct 2013
Q2 2013 $170K +$47K +38.2% 30 Jun 2013 10-Q 02 Aug 2013
Q1 2013 $84K -$45K -34.9% 31 Mar 2013 10-Q 13 May 2013
Q4 2012 $83K -$46K -35.7% 31 Dec 2012 10-K 24 Feb 2014
Q3 2012 $91K 30 Sep 2012 10-Q 05 Nov 2012
Q2 2012 $123K 30 Jun 2012 10-Q/A 15 Aug 2012
Q1 2012 $129K 31 Mar 2012 10-Q 14 May 2012
Q4 2011 $129K +$55K +74.3% 31 Dec 2011 10-K 21 Feb 2013
Q4 2010 $74K 31 Dec 2010 10-K 12 Mar 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.